Combating Economic Adulteration Of Regulated Goods
December 22, 2011, 1:59 PM EST
Law360, New York (December 22, 2011, 1:59 PM EST) -- Responding to a request from Reps. Henry Waxman, D-Calif., Frank Pallone, D-N.J., and John Dingell, D-Mich., on Oct. 24, 2011, the U.S. Government Accountability Office (GAO) issued a report which examines how the U.S. Food & Drug Administration (FDA) has addressed “economic adulteration” affecting the food and medical products it regulates.
The report recommends ways that the FDA can strengthen regulatory and enforcement policies to target economic adulteration, and documents gaps in the FDA’s authority which may compromise the agency’s capacity to identify economic adulteration cases,...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.